1697 related articles for article (PubMed ID: 29752398)
21. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug.
Saw J; Tzikas A; Shakir S; Gafoor S; Omran H; Nielsen-Kudsk JE; Kefer J; Aminian A; Berti S; Santoro G; Nietlispach F; Moschovitis A; Cruz-Gonzalez I; Stammen F; Tichelbäcker T; Freixa X; Ibrahim R; Schillinger W; Meier B; Sievert H; Gloekler S
JACC Cardiovasc Interv; 2017 Feb; 10(4):391-399. PubMed ID: 28231907
[TBL] [Abstract][Full Text] [Related]
22. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
[TBL] [Abstract][Full Text] [Related]
23. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
[TBL] [Abstract][Full Text] [Related]
24. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
[TBL] [Abstract][Full Text] [Related]
25. Delayed endothelialization of watchman device identified with cardiac CT.
Sivasambu B; Arbab-Zadeh A; Hays A; Calkins H; Berger RD
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1319-1324. PubMed ID: 31257658
[TBL] [Abstract][Full Text] [Related]
26. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
27. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
[TBL] [Abstract][Full Text] [Related]
28. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
[TBL] [Abstract][Full Text] [Related]
29. Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography.
Korsholm K; Jensen JM; Nørgaard BL; Nielsen-Kudsk JE
Circ Cardiovasc Interv; 2019 Sep; 12(9):e008112. PubMed ID: 31514523
[TBL] [Abstract][Full Text] [Related]
30. Follow-up imaging after left atrial appendage closure.
Kuroki K; Doshi SK; Whang W; Vanderzee S; Ducharme CB; Enomoto Y; Hanon S; Koruth JS; Miller MA; Choudry S; Sofi A; Langan N; Ellsworth B; Dukkipati SR; Reddy VY
Heart Rhythm; 2020 Nov; 17(11):1848-1855. PubMed ID: 32603780
[TBL] [Abstract][Full Text] [Related]
31. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
[TBL] [Abstract][Full Text] [Related]
32. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
[TBL] [Abstract][Full Text] [Related]
33. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry.
Sedaghat A; Vij V; Al-Kassou B; Gloekler S; Galea R; Fürholz M; Meier B; Valgimigli M; O'Hara G; Arzamendi D; Agudelo V; Asmarats L; Freixa X; Flores-Umanzor E; De Backer O; Søndergaard L; Nombela-Franco L; McInerney A; Korsholm K; Nielsen-Kudsk JE; Afzal S; Zeus T; Operhalski F; Schmidt B; Montalescot G; Guedeney P; Iriart X; Miton N; Saw J; Gilhofer T; Fauchier L; Veliqi E; Meincke F; Petri N; Nordbeck P; Rycerz S; Ognerubov D; Merkulov E; Cruz-González I; Gonzalez-Ferreiro R; Bhatt DL; Laricchia A; Mangieri A; Omran H; Schrickel JW; Rodes-Cabau J; Nickenig G
Circ Cardiovasc Interv; 2021 May; 14(5):e010195. PubMed ID: 34003661
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
[TBL] [Abstract][Full Text] [Related]
35. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
[TBL] [Abstract][Full Text] [Related]
36. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Left Atrial Appendage Patency After Device Closure.
Chen M; Yao PC; Fei ZT; Wang QS; Yu YC; Zhang PP; Li W; Zhang R; Mo BF; Zhao MZ; Yu Y; Yang M; Zhao Y; Gong CQ; Sun J; Li YG
Circ Cardiovasc Interv; 2024 May; 17(5):e013579. PubMed ID: 38629273
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
[TBL] [Abstract][Full Text] [Related]
40. Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure.
Spencer RJ; DeJong P; Fahmy P; Lempereur M; Tsang MYC; Gin KG; Lee PK; Nair P; Tsang TSM; Jue J; Saw J
JACC Cardiovasc Interv; 2015 Dec; 8(15):1935-1941. PubMed ID: 26738661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
